TGTX

TG Therapeutics, Inc. Announces First Quarter 2014 Financial Results and Business Update

[GlobeNewswire] – NEW YORK — TG Therapeutics, Inc. , an innovative clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of medically important pharmaceutical products … moreView todays social media effects on TGTXView the latest stocks trending across Twitter. Click to view dashboardSee who TG is hiring next, click here to view […]

Coronado Biosciences Announces February Inducement Award

[GlobeNewswire] – BURLINGTON, Mass. — Coronado Biosciences, Inc. inadvertently failed to file a press release as required by NASDAQ listing rule 5635c4 when it reported certain transactions on Form 8-K/A filed with the … moreView todays social media effects on TGTXView the latest stocks trending across Twitter. Click to view dashboardSee who TG is hiring next, click here to view […]

TG Therapeutics, Inc. to Host Conference Call on First Quarter 2014 Financial Results and Business Update

[GlobeNewswire] – NEW YORK — TG Therapeutics, Inc. , an innovative, clinical-stage biopharmaceutical company, today announced that a conference call will be held on Tuesday, May 13, 2014 at 8:30 a.m. ET to discuss results … moreView todays social media effects on TGTXView the latest stocks trending across Twitter. Click to view dashboardSee who TG is hiring next, click here […]

8:41 am TG Therapeutics provides update on a modified TGR-1202 formulation and Fed-State Dosing with data demonstrating significantly higher TGR-1202 Exposure; improvements in absorption are projected to increase exposure levels by ~ 3-4 fo

moreView todays social media effects on TGTXView the latest stocks trending across Twitter. Click to view dashboardSee who TG is hiring next, click here to view […]

TG Therapeutics, Inc. Provides Update on a Modified TGR-1202 Formulation and Fed-State Dosing With Data Demonstrating Significantly Higher TGR-1202 Exposure

[GlobeNewswire] – – Based on healthy subject bioequivalence studies, improvements in absorption are projected to increase exposure levels by approximately 3-4 fold moreView todays social media effects on TGTXView the latest stocks trending across Twitter. Click to view dashboardSee who TG is hiring next, click here to view […]

TG Therapeutics, Inc. Announces Clinical Data Presentations at Upcoming Conferences

[GlobeNewswire] – NEW YORK — TG Therapeutics, Inc. , today announced upcoming presentations of clinical data for TG-1101, the Company’s next generation, glycoengineered anti-CD20 monoclonal antibody and for TGR-1202, the … moreView todays social media effects on TGTXView the latest stocks trending across Twitter. Click to view dashboardSee who TG is hiring next, click here to view […]

TG Therapeutics, Inc. to Present at the 39th Annual Deutsche Bank Healthcare Conference

[GlobeNewswire] – NEW YORK — TG Therapeutics, Inc. , will participate in the 39th Annual Deutsche Bank Healthcare Conference being held at The InterContinental in Boston, MA. Michael S. Weiss, the Company’s Executive Chairman … moreView todays social media effects on TGTXView the latest stocks trending across Twitter. Click to view dashboardSee who TG is hiring next, click here to […]